Application of Internet Hospitals in the Disease Management of Patients With Ulcerative Colitis: Retrospective Study
View abstract on PubMed
Summary
This summary is machine-generated.Intelligent diagnosis and treatment via internet hospitals offers a feasible, accessible, and economical approach to managing ulcerative colitis (UC) by improving convenience and reducing medication costs.
Area Of Science
- Gastroenterology
- Digital Health
- Health Services Research
Background
- Ulcerative colitis (UC) is a chronic condition requiring long-term management, posing challenges in achieving remission and ensuring continuous care.
- Intelligent diagnosis, utilizing AI algorithms for symptom analysis and treatment recommendations, presents a potential method for UC management.
Purpose Of The Study
- To analyze ulcerative colitis (UC) diagnosis and treatment data from physical and internet hospitals.
- To highlight the benefits of the intelligent diagnosis and treatment service model offered by internet hospitals.
Main Methods
- Collected data from 852 UC patients at Tianjin Medical University General Hospital (July 2020 - June 2023).
- Employed statistical methods (chi-square, t-tests, rank-sum tests) to evaluate patient preferences and expenses.
- Compared service models, patient demographics, and costs between internet and physical hospitals.
Main Results
- Internet hospitals and physical hospitals exhibit distinct medical service models and patient demographics.
- Patients using internet hospitals primarily sought disease consultation and prescription medication (93.40%).
- A significant shift towards web-based or hybrid services for UC care was observed (58.57%), with younger patients preferring internet hospitals.
- Internet hospitals offered lower medication fees without compromising testing or examination costs.
Conclusions
- The intelligent diagnosis and treatment model via internet hospitals shows promise for UC management.
- Key benefits include feasibility, accessibility, convenience, and economic advantages.
- This model can enhance the continuity and efficiency of care for chronic conditions like UC.
Related Concept Videos
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Strictureplasty
Proctocolectomy or total colectomy with ileostomy
Restorative proctocolectomy with Ileal pouch-anal anastomosis
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...